Ratings by Wolfe Research (Kalpit Patel)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/8/2026 | Tango Therapeutics Inc. | TNGX | Upgrade | Outperform (Peerperform) |
20.22 (27.97) |
38.33% | Details | |
| 5/19/2026 | Tyra Biosciences | TYRA | New Coverage | Peerperform (N/A) |
35.66 (28.32) |
-20.58% | Details | |
| 5/19/2026 | Mirum Pharmaceuticals | MIRM | New Coverage | Outperform (N/A) |
95.49 (107.13) |
12.19% | Details | |
| 5/19/2026 | CytomX Therapeutics | CTMX | New Coverage | Outperform (N/A) |
3.50 (2.95) |
-15.71% | Details | |
| 5/19/2026 | CG Oncology | CGON | New Coverage | Peerperform (N/A) |
62.93 (61.08) |
-2.94% | Details | |
| 4/6/2026 | Soleno Therapeutics Inc. | SLNO | Downgrade | Peerperform (Outperform) |
39.49 (53.01) |
34.24% | Details | |
| 4/1/2026 | ORIC Pharmaceuticals | ORIC | Maintain | Peerperform (N/A) |
|
Details | ||
| 3/26/2026 | BeOne Medicines | ONC | New Coverage | Outperform (N/A) |
283.45 (270.15) |
-4.69% | Details | |
| 3/26/2026 | Krystal Biotech | KRYS | New Coverage | Peerperform (N/A) |
254.95 (348.06) |
36.52% | Details | |
| 3/26/2026 | Olema Pharmaceuticals | OLMA | New Coverage | Peerperform (N/A) |
14.17 (9.51) |
-32.89% | Details | |
| 3/26/2026 | Genmab A/S | GMAB | New Coverage | Outperform (N/A) |
26.11 (25.27) |
-3.22% | Details | |
| 3/25/2026 | Corcept Therapeutics | CORT | Upgrade | Peerperform (Underperform) |
33.82 (79.91) |
136.28% | Details | |
| 3/12/2026 | Celcuity Inc | CELC | Maintain | Outperform (N/A) |
|
Details | ||
| 3/9/2026 | ORIC Pharmaceuticals | ORIC | Maintain | Peerperform (N/A) |
|
Details | ||
| 3/2/2026 | Ascendis Pharma | ASND | Maintain | Outperform (N/A) |
|
Details | ||
| 1/12/2026 | Soleno Therapeutics Inc. | SLNO | Maintain | Outperform (N/A) |
|
Details | ||
| 12/31/2025 | Corcept Therapeutics | CORT | Downgrade | Underperform (Peerperform) |
70.19 (33.82) |
-51.82% | Details | |
| 11/18/2025 | Summit Therapeutics plc | SMMT | New Coverage | Peerperform (N/A) |
18.03 (13.75) |
-23.74% | Details | |
| 11/18/2025 | Tango Therapeutics Inc. | TNGX | New Coverage | Peerperform (N/A) |
8.17 (20.22) |
147.49% | Details | |
| 11/18/2025 | Scholar Rock | SRRK | New Coverage | Outperform (N/A) |
37.41 (47.33) |
26.52% | Details | |
| 11/18/2025 | Janux Therapeutics | JANX | New Coverage | Peerperform (N/A) |
29.28 (14.22) |
-51.43% | Details | |
| 11/18/2025 | Revolution | RVMD | New Coverage | Outperform (N/A) |
67.75 (162.99) |
140.58% | Details | |
| 11/18/2025 | Exelixis | EXEL | New Coverage | Peerperform (N/A) |
41.65 (51.91) |
24.63% | Details | |
| 11/18/2025 | Soleno Therapeutics Inc. | SLNO | New Coverage | Outperform (N/A) |
49.42 (53.01) |
7.26% | Details | |
| 11/18/2025 | ORIC Pharmaceuticals | ORIC | New Coverage | Peerperform (N/A) |
12.25 (8.49) |
-30.69% | Details | |
| 11/18/2025 | Arcellx Inc. | ACLX | New Coverage | Peerperform (N/A) |
89.98 (115.07) |
27.88% | Details | |
| 11/18/2025 | Ascendis Pharma | ASND | New Coverage | Outperform (N/A) |
204.40 (230.83) |
12.93% | Details | |
| 11/18/2025 | Corcept Therapeutics | CORT | New Coverage | Peerperform (N/A) |
75.54 (70.19) |
-7.08% | Details | |
| 11/18/2025 | Celcuity Inc | CELC | New Coverage | Outperform (N/A) |
92.68 (87.76) |
-5.31% | Details |
